Results 191 to 200 of about 10,087,786 (356)

Hippo pathway at the crossroads of stemness and therapeutic resistance in breast cancer

Molecular Oncology, EarlyView.
Dysregulation of the Hippo pathway drives nuclear accumulation of YAP/TAZ, activating stemness‐related transcriptional programs that sustain breast cancer stemness and fuel therapeutic resistance across subtypes, underscoring Hippo signaling as a targetable vulnerability. Figure created and edited with BioRender.com.
Giulia Schiavoni, Antonella Palmese, Stefano Scalera, Laura Cipriani, Davide Mascolo, Patrizia Vici, Teresa Arcuri, Lorena Filomeno, Eriseld Krasniqi, Giovanni Blandino, Giulia Bon, Marcello Maugeri‐Saccà   +11 more
wiley   +1 more source

Predictive modeling of gene expression and localization of DNA binding site using deep convolutional neural networks. [PDF]

PLoS Comput Biol
Karshenas A, Röschinger T, Garcia HG.
europepmc   +1 more source

Marking presence [PDF]

, 2012
Baker, Kate, Imre, S., Mitchell, Belinda
core  

CCDC80 suppresses high‐grade serous ovarian cancer migration via negative regulation of B7‐H3

Molecular Oncology, EarlyView.
PAX8 is a lineage‐specific master regulator of transcription in high‐grade serous ovarian cancer (HGSC) progression. We show for the first time that PAX8 facilitates proliferation and metastasis by repressing the cell autonomous tumor suppressor CCDC80 and inducing B7‐H3 expression.
Aya Saleh, Nitzan Medina‐Itzhaki, Milena Chekov, Eden Gal‐Swisa, Roba Gabesh‐Wahabi, Inbar Savyon, Inna Naroditsky, Hilary A. Kenny, Basem Fares, Lina Korsensky, Einav Girsh, Liron Berger, Ruth Perets   +12 more
wiley   +1 more source

Sites ou pages web sur l’Espagne contemporaine

Cahiers de Civilisation Espagnole Contemporaine, 2021
doaj   +1 more source

CD47 promotes mitogen‐activated protein kinase and epithelial‐to‐mesenchymal transition molecular programs to drive prometastatic phenotypes in non‐small cell lung cancer

Molecular Oncology, EarlyView.
Beyond its role in immune evasion, this study identified that CD47 drives tumor‐intrinsic signaling in non‐small cell lung cancer (NSCLC). Transcriptomic profiling and functional studies revealed that CD47 regulates cell adhesion, migration, and metastasis through an ERK–EMT signaling axis.
Asa P.Y. Lau, Lilian G. Zhai, Ryunosuke Hoshi, Zackary Rousseau, Abraam Zakhary, Yin Fang Wu, Rola M. Saleeb, Heyu Ni, Kelsie L. Thu   +8 more
wiley   +1 more source

Fire and Snow: Effects of Snowpack Variation and Wildfire on Small Mammal Dynamics in Sub-Alpine Habitats. [PDF]

Ecol Evol
Green KP, Happold DCD, Sanecki GM, Dickman CR.   +3 more
europepmc   +1 more source

Active Site and Oligosaccharide Recognition Residues of Peptide-N4-(N-acetyl-β -D-glucosaminyl)asparagine Amidase F [PDF]

, 1995
Peter Kühn, Chudi Guan, Tao Cui, Anthony L. Tarentino, Thomas H. Plummer, Patrick Van Roey   +5 more
openalex   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

Cross-Site Generalization of CNN-Based $$ {B}_1^{+} $$ Mapping in UHF MRI. [PDF]

NMR Biomed
Hadjikiriakos K, Krüger F, Zimmermann FF, Grimm JA, Schorling C, Lutz M, Schmidt S, Riemann LT, Degenhardt K, Schäffter T, Ladd ME, Metzger GJ, Aigner CS, Schmitter S.   +13 more
europepmc   +1 more source